Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Bandelow, Borwin
Bond, A.
Davidson, Jonathan R. T.
den Boer, J. A.
Fineberg, Naomi A.
Knapp, Martin
Scott, J.
and
Wittchen, H. -U.
2005.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
Journal of Psychopharmacology,
Vol. 19,
Issue. 6,
p.
567.
Uguz, Sukru
Seydaoglu, Gulsah
Doğan, Cem
Inanc, Banu Yazgan
Yurdagul, Ebru
and
Diler, Rasim Somer
2005.
Short-term antidepressant treatment of comorbid dental anxiety in patients with panic disorder.
Acta Odontologica Scandinavica,
Vol. 63,
Issue. 5,
p.
266.
Ator, Nancy A.
2005.
Contributions of GABAA Receptor Subtype Selectivity to Abuse Liability and Dependence Potential of Pharmacological Treatments for Anxiety and Sleep Disorders.
CNS Spectrums,
Vol. 10,
Issue. 1,
p.
31.
Lowry, Christopher A.
Johnson, Philip L.
Hay-Schmidt, Anders
Mikkelsen, Jens
and
Shekhar, Anantha
2005.
Modulation of anxiety circuits by serotonergic systems.
Stress,
Vol. 8,
Issue. 4,
p.
233.
Rowlett, James K.
Lelas, Snjezana
Tornatzky, Walter
and
Licata, Stephanie C.
2006.
Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors.
Psychopharmacology,
Vol. 184,
Issue. 2,
p.
201.
Rex, Andre
and
Fink, H.
2006.
Effects of 8-OH-DPAT on hippocampal NADH fluorescence in vivo in anaesthetized rats.
Journal of Neuroscience Research,
Vol. 83,
Issue. 4,
p.
551.
Lam, Raymond W.
2006.
Challenges in the treatment of anxiety disorders: beyond guidelines.
International Journal of Psychiatry in Clinical Practice,
Vol. 10,
Issue. sup3,
p.
18.
Kasper, Siegfried
2006.
Anxiety disorders: under-diagnosed and insufficiently treated.
International Journal of Psychiatry in Clinical Practice,
Vol. 10,
Issue. sup1,
p.
3.
Castagné, Vincent
Porsolt, Roger D.
and
Moser, Paul
2006.
Early behavioral screening for antidepressants and anxiolytics.
Drug Development Research,
Vol. 67,
Issue. 9,
p.
729.
Mirza, N. R.
and
Nielsen, E. Ø.
2006.
Do Subtype-Selective γ-Aminobutyric AcidA Receptor Modulators Have a Reduced Propensity to Induce Physical Dependence in Mice?.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 316,
Issue. 3,
p.
1378.
Duke, Angela N.
Platt, Donna M.
Cook, James M.
Huang, Shengming
Yin, Wenyuan
Mattingly, Bruce A.
and
Rowlett, James K.
2006.
Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes.
Psychopharmacology,
Vol. 187,
Issue. 3,
p.
321.
Shufflebotham, Jonathan
Hood, Sean
Hendry, Julie
Hince, Dana A
Morris, Kelly
Nutt, David
Probert, Chris
and
Potokar, John
2006.
Acute Tryptophan Depletion Alters Gastrointestinal and Anxiety Symptoms in Irritable Bowel Syndrome.
The American Journal of Gastroenterology,
Vol. 101,
Issue. 11,
p.
2582.
Gavioli, Elaine C.
and
Calo’, Girolamo
2006.
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.
Naunyn-Schmiedeberg's Archives of Pharmacology,
Vol. 372,
Issue. 5,
p.
319.
Capua, T.
and
Shapiro, C. M.
2007.
Commentary on a critique for the Journal of Psychopharmacology: NICE -excellence or eccentricity? Reflections on the z-drugs as hypnotics review.
Journal of Psychopharmacology,
Vol. 21,
Issue. 1,
p.
114.
Pellón, Ricardo
Ruíz, Ana
Lamas, Esmeralda
and
Rodríguez, Cilia
2007.
Pharmacological analysis of the effects of benzodiazepines on punished schedule-induced polydipsia in rats.
Behavioural Pharmacology,
Vol. 18,
Issue. 1,
p.
81.
Nishikawa, Hiroyuki
Inoue, Takeshi
Izumi, Takeshi
and
Koyama, Tsukasa
2007.
Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats.
European Neuropsychopharmacology,
Vol. 17,
Issue. 10,
p.
643.
Starr, Kathryn R
Price, Gary W
Watson, Jeannette M
Atkinson, Peter J
Arban, Roberto
Melotto, Sergio
Dawson, Lee A
Hagan, Jim J
Upton, Neil
and
Duxon, Mark S
2007.
SB-649915-B, a Novel 5-HT1A/B Autoreceptor Antagonist and Serotonin Reuptake Inhibitor, is Anxiolytic and Displays Fast Onset Activity in the Rat High Light Social Interaction Test.
Neuropsychopharmacology,
Vol. 32,
Issue. 10,
p.
2163.
Graeff, Frederico G
2007.
Ansiedade, pânico e o eixo hipotálamo-pituitária-adrenal.
Revista Brasileira de Psiquiatria,
Vol. 29,
Issue. suppl 1,
p.
s3.
Allgulander, C.
Jørgensen, T.
Wade, A.
François, C.
Despiegel, N.
Auquier, P.
and
Toumi, M.
2007.
Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial.
Current Medical Research and Opinion,
Vol. 23,
Issue. 10,
p.
2543.
Palucha, Agnieszka
and
Pilc, Andrzej
2007.
Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Pharmacology & Therapeutics,
Vol. 115,
Issue. 1,
p.
116.